# To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery

> **NCT02204813** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 13 (actual)

## Conditions studied

- Bypass, Gastric
- Roux-en-Y Gastric Bypass
- Vertical Sleeve Gastrectomy
- Gastric Banding
- Bariatric Surgery

## Interventions

- **DRUG:** Placebo
- **DRUG:** Lo-Xenin
- **DRUG:** Hi-Xenin
- **DRUG:** Extra Hi-Xenin

## Key facts

- **NCT ID:** NCT02204813
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-11-17
- **Final completion:** 2015-11-17
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02204813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02204813, "To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02204813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*